lovastatin has been researched along with Nervous System Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, KC; Mittal, A | 1 |
| Hoe, CM; Lankas, GR; Stoffregen, DA; Wise, LD | 1 |
| Bradford, RH; Chremos, AN; Downton, M; Dujovne, CA; Franklin, FA; Higgins, J; Nash, DT; Pool, JL; Schnaper, H; Shear, CL | 1 |
1 trial(s) available for lovastatin and Nervous System Diseases
| Article | Year |
|---|---|
Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Combined Modality Therapy; Creatine Kinase; Dietary Fats; Double-Blind Method; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Muscular Diseases; Nervous System Diseases | 1991 |
2 other study(ies) available for lovastatin and Nervous System Diseases
| Article | Year |
|---|---|
Childhood cerebral adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Blood Chemical Analysis; Brain; Child; Diet, Fat-Restricted; Humans; Hyperpigmentation; Lovastatin; Magnetic Resonance Imaging; Male; Nervous System Diseases | 2014 |
Juvenile toxicity assessment of open-acid lovastatin in rats.
Topics: Abnormalities, Drug-Induced; Animals; Anticholesteremic Agents; Behavior, Animal; Body Weight; Brain; Female; Lovastatin; Male; Motor Activity; Nervous System Diseases; Pregnancy; Rats; Rats, Sprague-Dawley | 2011 |